Japanese telecom company Softbank and Taiwanese electronics manufacturer Foxconn have announced that they plan to invest heavily in U.S. operations.
Softbank’s CEO announced that the company will invest $50 billion in America, with plans to create 50,000 new jobs. His news was delivered in the lobby of Trump Tower in Manhattan, following a meeting with the president-elect. The money will come from a $100 billion investment fund that Softbank has established with Saudi Arabia’s sovereign-wealth fund.
That announcement was swiftly followed by news from Foxconn—the company that manufactures devices for companies like Apple—explaining that it, too, plans to expand U.S. operations. In a statement, the company explained that “the scope of the potential investment has not been determined,” adding that final decisions will be made “following the completion of direct discussions between our leadership and the relevant U.S. officials.”
Donald Trump has already claimed credit for Softbank’s pledge. And it may be justified: its CEO mentioned increasing deregulation under Trump during his announcement.
If that is the case, the news could be a significant victory for Trump. The president-elect previously stated that he wanted to invigorate the manufacturing industry in the U.S., promising to “get Apple to start making their computers and their iPhones on our land, not in China.”
Apple is unlikely to shift production wholesale to the U.S., as China offers it cheap labor, a skilled workforce, and flexible factory facilities that domestic setups can’t currently match. But if Foxconn does expand operations in America, Apple may tempted to manufacture more of its goods on American soil.
Indeed, its hand may be forced in the coming weeks. Trump is said to be inviting the Silicon Valley elite to a roundtable discussion next week. It’s not clear what will be on the agenda, or who exactly will attend—though chief executives of Oracle and Cisco Systems are confirmed.
Whoever shows up, Trump will certainly try to convince attendees that they should be building their products in the U.S. It will be a meeting that could potentially shape the next four years of technological change—and where it’s made.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.